Systemic Absortion and Adverse Effects of Topical Ocular Use of Ketorolac Tromethamine and Sodium Diclofenac in New Zealand Rabbits for 90 Days

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia - Brazil
doi 10.1590/1678-4162-10219
Full Text
Abstract

Available in full text

Categories
Veterinary
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Lipid Nanocapsule-Based Gels for Enhancement of Transdermal Delivery of Ketorolac Tromethamine

Journal of Drug Delivery
2011English

Pharmacokinetics of Ketorolac Tromethamine in Horses After Intravenous, Intramuscular, and Oral Single-Dose Administration

Journal of Veterinary Pharmacology and Therapeutics
VeterinaryPharmacology
2015English

Formulation, Development and Evaluation of Colon-Specific Ketorolac Tromethamine Compression Coated Tablets

Science, Technology and Arts Research Journal
2016English

Preparation, Characterization and In-Vitro Release of Controlled Release Ketorolac Tromethamine Cellulose Acetate Butyrate Microspheres

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2010English

Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits

European Journal of Drug Metabolism and Pharmacokinetics
Pharmacology
2016English

Management of Adverse Effects of Topical PDT

British Journal of Dermatology
DermatologyMedicine
2019English

Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Influence of Ultrasound on the Percutaneous Absorption of Ketorolac Tromethamine in Vitro Across Rat Skin

Drug Delivery
MedicinePharmaceutical Science
2004English

Lick Rates in New Zealand White Rabbits

Bulletin of the Psychonomic Society
1973English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy